Skip to Main Content

Author Details

Steven W Millward
University of Texas MD Anderson Cancer Center
2002
43
18
PMIDPaper TitleJournal TitlePublished Year
36705543Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease.Neuro Oncol2023
37915607Membrane anchoring of the DIRAS3 N-terminal extension permits tumor suppressor function.iScience2023
38003754Enolase Inhibitors as Early Lead Therapeutics against <i>Trypanosoma brucei</i>.Pathogens2023
37568603Gender Differences in a Mouse Model of Hepatocellular Carcinoma Revealed Using Multi-Modal Imaging.Cancers (Basel)2023
37214825Anaplerotic nutrient stress drives synergy of angiogenesis inhibitors with therapeutics targeting tumor metabolism.bioRxiv2023
36798479Comparative Pharmacology of a Bis-Pivaloyloxymethyl Phosphonate Prodrug Inhibitor of Enolase after Oral and Parenteral Administration.ACS Pharmacol Transl Sci2023
36251833Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of <i>ENO1</i>-Deleted Cancers.J Med Chem2022
35611948Directed Evolution of PD-L1-Targeted Affibodies by mRNA Display.ACS Chem Biol2022
35732988PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[<sup>18</sup>F]Fluoroglutamine.Mol Imaging Biol2022
35792073Quantification of Phosphonate Drugs by <sup>1</sup>H-<sup>31</sup>P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice.Anal Chem2022
36140078Apoptosis Detection in Retinal Ganglion Cells Using Quantitative Changes in Multichannel Fluorescence Colocalization.Biosensors (Basel)2022
34163626Directed evolution of cyclic peptides for inhibition of autophagy.Chem Sci2021
35937580NMR Spectroscopy-Based Metabolomics of Platelets to Analyze Brain Tumors.Reports (MDPI)2021
33799686Prolyl Hydroxylase 3 Knockdown Accelerates <i>VHL</i>-Mutant Kidney Cancer Growth In Vivo.Int J Mol Sci2021
34137725Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer.JMIR Med Inform2021
34165126Directing evolution of novel ligands by mRNA display.Chem Soc Rev2021
32352272mRNA Display Discovery of a Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1).ACS Chem Biol2020
31919017Purification of poly-dA oligonucleotides and mRNA-protein fusions with dT25-OAS resin.Bioorg Med Chem Lett2020
33043224Mammalian Expression and <i>In Situ</i> Biotinylation of Extracellular Protein Targets for Directed Evolution.ACS Omega2020
32519246Mistiming Death: Modeling the Time-Domain Variability of Tumor Apoptosis and Implications for Molecular Imaging of Cell Death.Mol Imaging Biol2020
29748904Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo.Mol Imaging Biol2019
31387889Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia.Mol Cancer Ther2019
313911926-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.Clin Cancer Res2019
31003488DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1.Cancers (Basel)2019
30680862Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy.Angew Chem Int Ed Engl2019
30168713Caspase-3 Substrates for Noninvasive Pharmacodynamic Imaging of Apoptosis by PET/CT.Bioconjug Chem2018
30112590Bioactive lipid metabolism in platelet "first responder" and cancer biology.Cancer Metastasis Rev2018
28762014Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.Cancer Metastasis Rev2017
28150941Automated, Resin-Based Method to Enhance the Specific Activity of Fluorine-18 Clicked PET Radiotracers.Bioconjug Chem2017
27465925Directed Evolution of Scanning Unnatural-Protease-Resistant (SUPR) Peptides for in Vivo Applications.Chembiochem2016
27784287Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models.BMC Cancer2016
25901825A protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH domain of Akt1.Nat Chem2015
26247722ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts.Cell Death Dis2015
25234472Serum stable natural peptides designed by mRNA display.Sci Rep2014
22836343In situ click chemistry: from small molecule discovery to synthetic antibodies.Integr Biol (Camb)2013
24254999A chemical epitope-targeting strategy for protein capture agents: the serine 474 epitope of the kinase Akt2.Angew Chem Int Ed Engl2013
23977006A catalyzing phantom for reproducible dynamic conversion of hyperpolarized [1-¹³C]-pyruvate.PLoS One2013
21962254Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1.J Am Chem Soc2011
19301344Iterative in situ click chemistry creates antibody-like protein-capture agents.Angew Chem Int Ed Engl2009
17894440Design of cyclic peptides that bind protein surfaces with antibody-like affinity.ACS Chem Biol2007
16218582A general route for post-translational cyclization of mRNA display libraries.J Am Chem Soc2005
14652071Encodamers: unnatural peptide oligomers encoded in RNA.Chem Biol2003
12188645In vitro selection of mRNA display libraries containing an unnatural amino acid.J Am Chem Soc2002
  • 1 - 43 of 43

Recommended Authors

Daniel Carbajo
Institut de Quimica Avancada de Catalunya (IQAC-CSIC)
Career Start Year 2011
Number of shared co-authors 1
Nir London
The Weizmann Institute of Science
Career Start Year 2007
Number of shared co-authors 0
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 0
Seulki Lee
The Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Natalia Sevillano
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2004
Number of shared co-authors 0
Luke L Lairson
The Scripps Research Institute
Career Start Year 2003
Number of shared co-authors 0
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 0
Gopal Iyer
University of Wisconsin School of Medicine and Public Health, University of Wisconsin
Career Start Year 2002
Number of shared co-authors 0
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Huib Ovaa
Leiden University Medical Center
Career Start Year 2002
Number of shared co-authors 0
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
Ningyan Zhang
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 2
Vineet Gupta
Purdue University
Career Start Year 1999
Number of shared co-authors 0
Pavel Strop
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 0
Jack Taunton
University of California san francisco
Career Start Year 1996
Number of shared co-authors 0
Ranjini K Sundaram
Yale University
Career Start Year 1996
Number of shared co-authors 0
Paul J Hergenrother
University of Illinois at Urbana-Champaign
Career Start Year 1995
Number of shared co-authors 0
Zhuyin Li
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
Michael Ohlmeyer
Atux Iskay LLC
Career Start Year 1993
Number of shared co-authors 0
Carolyn R Bertozzi
Stanford University
Career Start Year 1992
Number of shared co-authors 0
Zhiqiang An
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 2
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 0
Dale J Christensen
TFF Pharmaceuticals, Inc.
Career Start Year 1992
Number of shared co-authors 0
Michael A Whitney
University of California San Diego
Career Start Year 1990
Number of shared co-authors 0
Timothy A Lewis
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 1
Christopher P Austin
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 0
Renata Pasqualini
Rutgers Cancer Institute of New Jersey
Career Start Year 1988
Number of shared co-authors 4
Kevan M Shokat
University of California San Francisco
Career Start Year 1987
Number of shared co-authors 0
Stuart L Schreiber
Broad Institute
Career Start Year 1985
Number of shared co-authors 0
Wadih Arap
Rutgers Cancer Institute of New Jersey
Career Start Year 1983
Number of shared co-authors 4

Collaborators

Niki M Zacharias
MD Anderson Cancer Center
Co-authored papers 10
Argentina Ornelas
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Pratip Bhattacharya
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
James R Heath
Institute of Systems Biology, University of Washington
Co-authored papers 5
Shivanand Pudakalakatti
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Ernest T Hawk
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Prasanta Dutta
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Jos?? S Enriquez
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Vincenzo Paolillo
UT MD Anderson Cancer Center
Co-authored papers 2
Nikunj Satani
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Takashi Shingu
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Laura Beretta
Co-authored papers 1
Jian Zhang
Louisiana State University
Co-authored papers 1
Eugene Lurie
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Xiaoqian Jiang
Carnegie Mellon University, The University of Texas Health Science Center at Houston, University of California San Diego
Co-authored papers 1
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 1
Kanglin Hsieh
University of Texas Health Science Center at Houston
Co-authored papers 1
Eleni Efstathiou
Houston Methodist Cancer Center
Co-authored papers 1
Yan-Xia Chu
Qilu Hospital of Shandong University
Co-authored papers 1
Subrata Sen
UT MD Anderson Cancer Center
Co-authored papers 1
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Co-authored papers 1
Xiaowen Liang
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Duncan Salmon
Rice University
Co-authored papers 1
Ann M Killary
The University of Texas M. D. Anderson Cancer Center
Co-authored papers 1
Release 1.2